Development of sarcoidosis during anti-TNF-α treatment

What is the mechanism?

Jaeil Shin, Dong Soo Kim

Research output: Contribution to journalLetter

1 Citation (Scopus)
Original languageEnglish
Number of pages1
JournalClinical and Experimental Rheumatology
Volume27
Issue number6
Publication statusPublished - 2009 Dec 1

Fingerprint

Antirheumatic Agents
Sarcoidosis
Tumor Necrosis Factor-alpha
Monoclonal Antibodies

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Cite this

@article{b0e93c230f3e4bdb8edfaf7c722ec6d2,
title = "Development of sarcoidosis during anti-TNF-α treatment: What is the mechanism?",
author = "Jaeil Shin and Kim, {Dong Soo}",
year = "2009",
month = "12",
day = "1",
language = "English",
volume = "27",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "6",

}

Development of sarcoidosis during anti-TNF-α treatment : What is the mechanism? / Shin, Jaeil; Kim, Dong Soo.

In: Clinical and Experimental Rheumatology, Vol. 27, No. 6, 01.12.2009.

Research output: Contribution to journalLetter

TY - JOUR

T1 - Development of sarcoidosis during anti-TNF-α treatment

T2 - What is the mechanism?

AU - Shin, Jaeil

AU - Kim, Dong Soo

PY - 2009/12/1

Y1 - 2009/12/1

UR - http://www.scopus.com/inward/record.url?scp=76649112390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76649112390&partnerID=8YFLogxK

M3 - Letter

VL - 27

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 6

ER -